[go: up one dir, main page]

AU2003212634A1 - Compounds useful in the treatment of cancer - Google Patents

Compounds useful in the treatment of cancer

Info

Publication number
AU2003212634A1
AU2003212634A1 AU2003212634A AU2003212634A AU2003212634A1 AU 2003212634 A1 AU2003212634 A1 AU 2003212634A1 AU 2003212634 A AU2003212634 A AU 2003212634A AU 2003212634 A AU2003212634 A AU 2003212634A AU 2003212634 A1 AU2003212634 A1 AU 2003212634A1
Authority
AU
Australia
Prior art keywords
cancer
treatment
compounds useful
compounds
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003212634A
Other versions
AU2003212634A8 (en
Inventor
Alexander Chausovsky
Dan Jacob Gelvan
Lev Goltsman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZETIQ TECHNOLOGIES Ltd
Original Assignee
ZETIQ TECHNOLOGIES Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZETIQ TECHNOLOGIES Ltd filed Critical ZETIQ TECHNOLOGIES Ltd
Publication of AU2003212634A8 publication Critical patent/AU2003212634A8/en
Publication of AU2003212634A1 publication Critical patent/AU2003212634A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003212634A 2002-03-11 2003-03-11 Compounds useful in the treatment of cancer Abandoned AU2003212634A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36299602P 2002-03-11 2002-03-11
US60/362,996 2002-03-11
US41715402P 2002-10-10 2002-10-10
US60/417,154 2002-10-10
PCT/IL2003/000198 WO2003075828A2 (en) 2002-03-11 2003-03-11 Compounds useful in the treatment of cancer

Publications (2)

Publication Number Publication Date
AU2003212634A8 AU2003212634A8 (en) 2003-09-22
AU2003212634A1 true AU2003212634A1 (en) 2003-09-22

Family

ID=27807983

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003212634A Abandoned AU2003212634A1 (en) 2002-03-11 2003-03-11 Compounds useful in the treatment of cancer

Country Status (2)

Country Link
AU (1) AU2003212634A1 (en)
WO (1) WO2003075828A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1805142A4 (en) 2004-09-23 2009-06-10 Reddy Us Therapeutics Inc Novel pyridine compounds, process for their preparation and compositions containing them
EP1877388A2 (en) * 2005-02-25 2008-01-16 Kudos Pharmaceuticals Ltd Hydrazinomethyl, hydrazonomethyl and 5-membered heterocylic compounds which act as mtor inhibitors and their use as anti cancer agents
JP2008534472A (en) * 2005-03-22 2008-08-28 ノイロサーチ アクティーゼルスカブ Pyrazolyl-pyrimidine and its medical use as potassium channel modulators
US20090215777A1 (en) * 2005-05-19 2009-08-27 Astex Therapeutics Ltd. Pyrimidine Derivatives As HSP90 Inhibitors
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
JP2009518364A (en) * 2005-12-08 2009-05-07 ラボラトワール セローノ ソシエテ アノニム Pyrimidyl, condensed pyrimidyl, pyridylhydrazone that suppresses growth
WO2010026087A1 (en) * 2008-09-02 2010-03-11 Neurosearch A/S Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators
WO2010034707A1 (en) 2008-09-26 2010-04-01 Neurosearch A/S Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
PT2595965T (en) 2010-07-20 2016-08-22 Vestaron Corp Insecticidal triazines and pyrimidines
CN103974955B (en) 2011-08-23 2018-06-19 阿萨纳生物科技有限责任公司 Pyrimido-pyridazinone compounds and uses thereof
CN103193691B (en) * 2012-01-06 2017-08-25 中国科学院上海药物研究所 Sulfonamides compound, pharmaceutical composition and its preparation method and application
DK2922828T3 (en) 2012-11-21 2020-08-31 Ptc Therapeutics Inc 4,6-DIAMINO-PYRIMIDINE DERIVATIVES AS BMI-1 INHIBITORS TO TREAT CANCER
US10584115B2 (en) 2013-11-21 2020-03-10 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine BMI-1 inhibitors
WO2016020288A1 (en) 2014-08-04 2016-02-11 Nuevolution A/S Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
AU2017275657B2 (en) 2016-06-02 2021-08-19 Novartis Ag Potassium channel modulators
EP3571193B1 (en) 2017-01-23 2021-12-01 Cadent Therapeutics, Inc. Potassium channel modulators
CA3060316A1 (en) 2017-04-28 2018-11-01 Asana Biosciences, Llc Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredient
BR112021002630A2 (en) 2018-08-17 2021-05-11 Ptc Therapeutics, Inc. method to treat pancreatic cancer
EP3870291A1 (en) 2018-10-22 2021-09-01 Cadent Therapeutics, Inc. Crystalline forms of potassium channel modulators
EP4076657A1 (en) 2019-12-20 2022-10-26 Nuevolution A/S Compounds active towards nuclear receptors
JOP20220160A1 (en) 2019-12-20 2023-01-30 Nuevolution As Compounds active towards nuclear receptors
MX2022012260A (en) 2020-03-31 2022-11-30 Nuevolution As COMPOUNDS ACTIVE AGAINST NUCLEAR RECEPTORS.
MX2022012259A (en) 2020-03-31 2022-12-08 Nuevolution As COMPOUNDS ACTIVE AGAINST NUCLEAR RECEPTORS.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281358B1 (en) * 1999-04-15 2001-08-28 American Cyanamid Company Process for the preparation of substituted pyrimidines
GB9924862D0 (en) * 1999-10-20 1999-12-22 Celltech Therapeutics Ltd Chemical compounds

Also Published As

Publication number Publication date
AU2003212634A8 (en) 2003-09-22
WO2003075828A3 (en) 2003-12-24
WO2003075828A2 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
AU2003213144A1 (en) Alkylating agent combinations in the treatment of cancer
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2003209594A1 (en) Quinazoline compounds useful in therapy
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
AUPS054702A0 (en) Cancer therapy
AU2003249244A1 (en) Methods for the treatment of neoplasms
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
AUPS328002A0 (en) Water treatment
AU2003222449A1 (en) Medicine for treating cancer
AU2003247005A1 (en) Therapy combination
IL165839A0 (en) Compounds useful for the treatment of cancer compositions thereof and methods therewith
AU2003258662A1 (en) Use of 4-amino-quinazolines as anti cancer agents
AU2003219160A1 (en) Methods and compositions for the treatment of cancer
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AU2003251875A1 (en) Combination therapy for the treatment of neoplasms
AU2003223538A1 (en) Methods for the treatment of cancer
AU2003296545A1 (en) Use of a trpm8-activating substance for the treatment of tumours
AU2003231803A1 (en) Treatment of cancer with mefloquire
AU2003302625A1 (en) Silicon compounds useful in cancer therapy
AU2003296242A1 (en) Thia-epothilone derivatives for the treatment of cancer
AU2003283339A1 (en) Cancer therapy determination
AU2004281077A1 (en) Methods and agents for the treatment of cancer
AU2002305138A1 (en) Methods and materials for cancer treatment
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2003247094A1 (en) Enhancing the effect of radioimmunotherapy in the treatment of tumors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase